Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Tell a Convincing Story: Tips from the Experts on How to Secure Research Grants

Thomas R. Collins  |  Issue: February 2021  |  January 22, 2021

But a “thick skin” is also vital, he said.

“Once you become an assistant professor, you realize that rejection becomes an everyday part of life. Your paper’s rejected, your grant’s rejected, and you have to be persistent and tough,” Dr. Robinson said. “Over time, you will have successful grants, and you will have successful papers.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Checklist for Success
John Peyman, PhD, a subject matter expert at the National Institute of Allergy and Infectious Diseases (NIAID), said applicants must persuade reviewers that their project is both significant and feasible. “Expertise in basic science or clinical research does not guarantee that you will get a grant,” he said.

John Peyman

John Peyman

Dr. Peyman presented a checklist of 40 actions derived from discussions by peer reviewers of thousands of applications over many years. Addressing these items will give an application the best chance of success, he said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In the “Significance” category, the checklist items include being sure a project has “important implications that expert reviewers in my field will understand” and that the research will not just confirm previous work in the field.

“Critically recapitulating the state of the art, including your own preliminary data, focuses the reviewers’ attention on reasons to do the study,” Dr. Peyman suggested.

To demonstrate “Innovation,” applicants need to assure reviewers the project will “move the field forward in a major way.” “A common criticism is that plans, if completed, would produce merely incremental progress in the field,” he said.

The “My Thinking and Writing” checklist section suggests making sure sentences are clear and strong, tailoring the writing to a specific study section’s scope and members, and incorporating constructive criticism to strengthen an application’s reasoning.

To demonstrate “Feasibility,” an applicant should make sure the proposed methods have been published, that a project isn’t over-ambitious and that they explain the feasibility of every aim of the project. If reviewers don’t understand the methods and resources the applicant has available, they might “ding you for lack of feasibility,” Dr. Peyman said.

Under “Strategy and Resources,” checklist items include making sure to list the expected results, explain how the methods will achieve robust and unbiased results and respond effectively to reviewer critiques.

The “Specific Aims” items include showing that each aim of a project will test a hypothesis based on the researcher’s preliminary data and assuring reviewers that each aim can be completed independent of the outcome of the other aims.

Page: 1 2 3 | Single Page
Share: 

Filed under:ACR ConvergenceMeeting Reports Tagged with:ACR Convergence 2020John PeymanKaren CostenbaderNIH research fundingResearch FundingWilliam Robinson

Related Articles

    Clinical Rheumatology Year in Review 2021

    November 22, 2021

    ACR Convergence 2021—On Nov. 5, Karen H. Costenbader, MD, MPH, professor of medicine, Harvard Medical School, and director of the lupus program, Brigham and Women’s Hospital, Boston, gave a whirlwind review of the most important clinical rheumatology publications of the past year. Testing New Medications for Rheumatic Disease ADVOCATE Trial of Avacopan ad goes here:advert-1ADVERTISEMENTSCROLL…

    Aims Review Committee Helps Rheumatology Researchers Craft Grant Proposals

    August 13, 2017

    There you are, working steadily away on your next manuscript. The ideas are flowing. You’ve hit your stride. Nothing can stop you now—nothing, that is, except a colleague who shows up at your desk with a 20-page grant proposal. “Do you mind?” he asks. Across academia the problem is the same—too few hours in the…

    Gorodenkoff / shutterstock.com

    The NIAMS Diversity Supplement Program Offers Researcher Funding

    January 10, 2022

    The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is a component of the National Institutes of Health (NIH) that supports research into the causes, treatment and prevention of arthritis and musculoskeletal and skin diseases, as well as the training of basic and clinical scientists to carry out this research. NIAMS recognizes the…

    Is It Time to Replace the HAQ?

    July 12, 2011

    The PROMIS initiative uses item response theory to improve assessment of patient-reported health and wellbeing

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences